Evidence map›Paper›PMID 40442205›Full record

ArticleScientific reports2025

Population-based estimates of different dosage types of psychedelic use across socio-demographic groups in Germany.

Sebastian Sattler, Suzanne Wood, Margit Anne Petersen, Fiona Seiffert, Guido Mehlkop

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sebastian SattlerFaculty of Sociology, Bielefeld University, 33615, Bielefeld, Germany. sebastian.sattler@uni-bielefeld.de.ORCID http://orcid.org/0000-0002-6491-0754
Suzanne WoodDepartment of Psychology, University of Toronto, Toronto, M5S 3G3, Canada.ORCID http://orcid.org/0000-0003-3734-8927
Margit Anne PetersenCenter for Alcohol and Drug Research, Aarhus Universitet, Copenhagen, 2400, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-9145-6745
Fiona SeiffertFaculty of Sociology, Bielefeld University, 33615, Bielefeld, Germany.ORCID http://orcid.org/0009-0000-0800-3626
Guido MehlkopFaculty of Economics, Law and Social Sciences, University of Erfurt, Erfurt, 99089, Germany.ORCID http://orcid.org/0000-0003-3095-6188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychedelic drugs, particularly taking small amounts of psychedelics in a cyclical pattern over days (so-called microdosing), have garnered growing scientific and public interest, but representative data on different dosage levels is scarce. To better understand this trend, we surveyed a nationwide sample of 11,299 adults in Germany. The survey assessed lifetime and past six-month psychedelic use by dosage as well as socio-demographic variables (sex, age, education, employment status, household equivalence income, partner arrangements, and place of residence). Results show that 5.0% of respondents self-reported lifetime psychedelic use, while 0.7% reported past six-month use. Medium to high dosing was more prevalent than microdosing. Moreover, high probabilities of using multiple forms of psychedelics were uncovered. We also observed variation in use across socio-demographic groups. For example, psychedelics use was less likely in females than males, and older than younger respondents. Past six-month microdosing was less likely in rural areas, and past six-month medium to high dosing was less prevalent in individuals with higher income or who live with a partner. This study shows limited support for widespread use in Germany and highlights diverse usage patterns across socio-demographics. These findings can inform policies, especially considering the overlap in usage of various substances.

Indexed as

HallucinogensAdolescentAdultAgedFemaleGermanyHumansMaleMiddle AgedSocioeconomic FactorsSurveys and QuestionnairesYoung AdultHallucinogens

Identifiers

PMID40442205
PMCPMC12122786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.